BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/02/2019

FDA Announces Draft Guidance for Eosinophilic Esophagitis Treatment

The FDA has released a draft guidance document to aid pharmaceutical companies in developing treatments for eosinophilic esophagitis, a condition that affects the esophagus, and invites industry stakeholders to provide feedback.

Source: Federal Register — Food and Drug AdministrationOpen original release →